Form 4 for CL Colgate-Palmolive
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001225208-24-008718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-12 | CL | SUTULA STANLEY J III | CFO | A - Grant | $0.00 | +5,455 | 37.9K | +17% | $0 |
| D | 2024-09-16 | 2024-09-13 | CL | SUTULA STANLEY J III | CFO | F - Tax | $105.73 | -1,143 | 36.7K | -3% | -$120.8K |
| D | 2024-09-16 | 2024-09-12 | CL | SUTULA STANLEY J III | CFO | A - Grant | $0.00 | +38.4K | 38.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | A | A | 5,455 | $0.00 | 37,869 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-13 | F | D | 1,143 | $105.73 | 36,726 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-09-12 | A | A | 38,411 | $0.00 | 38,411 | D | $106.34 · — to 2032-09-12 | 38,411 Common Stock | (F4) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 12, 2024 grant date. |